Chemoimmunotherapy before surgery increases survival in lung cancer

Chemoimmunotherapy before surgery increases survival in lung cancer

Oncology

IASLC Global Conference on Lung Cancer 2022

A combination of chemotherapy and neoadjuvant immunotherapy not only “shrinks” the lung tumor, but also increases survival.

Performing CT scans for covid-19 pneumonia has helped diagnose more lung cancers, but not always in the early stages, SEOM warns.

#Chemoimmunotherapy #surgery #increases #survival #lung #cancer

Leave a Reply